Cytogen Corp said expand clinical trial cancer imaging technology .
It said new study anticipated begin mid year .
It said first phase human testing begain October .
The technology us monocloncal antibody tagged radioisotope diagnose colorectal cancer several cancer type .
It said preliminary study revealed antibody combination well tolerated patient studied .
Reuter & # 3 ; 